Top biotechnology-immunotherapy
in Germany

Sector Depth

Germany has established itself as a critical hub for biotechnology-immunotherapy innovation. The following list highlights the dominant market players currently headquartered or primarily operating within the Germany region, sorted by overall market impact and revenue scale heading into 2026.

biotechnology-immunotherapy Leaderboard: Germany

BioNTech SE

BioNTech company profile covering history, FY2025 revenue, founders, CEO Prof. Ugur Sahin, M.D., business model, competitors, and official sources.

Read full company history of BioNTech SE

Strategy Note

The biotechnology-immunotherapy sector in Germany is characterized by high strategic focus and niche dominance. Companies in this region often benefit from local regulatory frameworks and accessible talent pools specific to Germany.

Analysis Status100% Data Coverage

Market OutlookGrowth Projection: Strong

Frequently Asked Questions

Who is the biggest biotechnology-immunotherapy company in Germany?

Currently, BioNTech SE holds the top position in Germany within the biotechnology-immunotherapy sector, based on reported revenue and market valuation.

How competitive is biotechnology-immunotherapy in Germany?

With 1 major players analyzed, the biotechnology-immunotherapy market in Germany shows a concentrated landscape.

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.